Superior Genomics, Inc.
PrivateLast Round
Seed Round
Aug 14, 2026
Total Funding Raised
$4,100
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Superior Genomics, Inc. is a health technology company that develops blood-based gene expression diagnostic tests for mental health disorders such as Major Depressive Disorder and Bipolar Disorder.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Mental Health, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Superior Genomics, Inc. Comparables
Compare Superior Genomics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Laguna Diagnostics, LLC | 85% | |
| MindX Sciences | 83% | |
| ALCEN | 82% | |
Superior Genomics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 14, 2026 | ||||
| Grant | Dec 1, 2024 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 14, 2026
$508K raised in Seed Round.
- Dec 1, 2024
Received $4.1K grant from Central Upper Peninsula Small Business Support Hub.
Superior Genomics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Superior Genomics, Inc.'s valuation, stock price, and market status.